Eventide Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-130,000
| Closed | -$6.55M | – | 150 |
|
|
2018
Q3 | $6.55M | Hold |
130,000
| – | – | 0.24% | 95 |
|
|
2018
Q2 | $7.78M | Hold |
130,000
| – | – | 0.32% | 81 |
|
|
2018
Q1 | $5.95M | Hold |
130,000
| – | – | 0.28% | 87 |
|
|
2017
Q4 | $5.18M | Hold |
130,000
| – | – | 0.27% | 82 |
|
|
2017
Q3 | $5.2M | Sell |
130,000
-39,000
| -23% | -$1.56M | 0.29% | 76 |
|
|
2017
Q2 | $7.28M | Sell |
169,000
-201,000
| -54% | -$8.66M | 0.45% | 57 |
|
|
2017
Q1 | $11.6M | Sell |
370,000
-75,000
| -17% | -$2.35M | 0.77% | 46 |
|
|
2016
Q4 | $11.2M | Hold |
445,000
| – | – | 0.73% | 48 |
|
|
2016
Q3 | $11M | Sell |
445,000
-130,000
| -23% | -$3.21M | 0.67% | 48 |
|
|
2016
Q2 | $11.7M | Hold |
575,000
| – | – | 0.72% | 49 |
|
|
2016
Q1 | $8.77M | Buy |
575,000
+77,000
| +15% | +$1.17M | 0.49% | 57 |
|
|
2015
Q4 | $6.69M | Buy |
498,000
+149,400
| +43% | +$2.01M | 0.33% | 72 |
|
|
2015
Q3 | $4.89M | Buy |
348,600
+62,000
| +22% | +$870K | 0.28% | 75 |
|
|
2015
Q2 | $4.87M | Hold |
286,600
| – | – | 0.26% | 75 |
|
|
2015
Q1 | $3.47M | Buy |
286,600
+29,600
| +12% | +$358K | 0.26% | 77 |
|
|
2014
Q4 | $2.13M | Hold |
257,000
| – | – | 0.23% | 77 |
|
|
2014
Q3 | $2.23M | Buy |
257,000
+16,400
| +7% | +$142K | 0.31% | 67 |
|
|
2014
Q2 | $2.64M | Buy |
240,600
+25,100
| +12% | +$275K | 0.36% | 70 |
|
|
2014
Q1 | $1.93M | Buy |
+215,500
| New | +$1.93M | 0.3% | 69 |
|